Skip to content

Clinical trials

Phase 3 Mental Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 3 Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20032
20043
20052
20062
20073
20086
20093
20109
20118
20123
20137
20143
20151
20162
20173
20182
20201
20221
20233
20246
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71
Terminated6
Recruiting5
Active, not recruiting4
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.15
National Center for Research Resources (NCRR)9
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.6
Merck Sharp & Dohme LLC5
National Institute of Neurological Disorders and Stroke (NINDS)5
AstraZeneca4
H. Lundbeck A/S4
Forest Laboratories3
Eli Lilly and Company2
Iris Sommer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders90
Schizophrenia18
Dementia16
Nervous System Diseases16
Neurologic Manifestations16
Alzheimer Disease14
Psychotic Disorders14
Rare Diseases14
Brain Diseases12
Central Nervous System Diseases12

Trials

Showing 26 to 50 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.